Pregnancy under everolimus-based immunosuppression

被引:37
|
作者
Veroux, Massimiliano [1 ]
Corona, Daniela [1 ]
Veroux, Pierfrancesco [1 ]
机构
[1] Univ Hosp Catania, Dept Surg Transplantat & Adv Technol, Vasc Surg & Organ Transplant Unit, I-95128 Catania, Italy
关键词
everolimus; kidney; pregnancy; transplantation; TRANSPLANT RECIPIENT; SIROLIMUS;
D O I
10.1111/j.1432-2277.2011.01356.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
The ability to give birth to a live child is one of the best success of kidney transplantation. While there are an increasing number of pregnancies reported in kidney transplant recipients treated with cyclosporine or tacrolimus, there is little evidence of pregnancy among kidney transplant recipients exposed to sirolimus or everolimus. We present the first successful delivery in an organ transplant recipient exposed to everolimus during the whole gestation. The absence of congenital anomalies in the child as well as the recipient's successful renal outcome are promising, although pregnancy in renal transplant recipients exposed to everolimus should be considered at higher risk.
引用
收藏
页码:E115 / E117
页数:3
相关论文
共 50 条
  • [21] Pubertal Development After Pediatric Kidney Transplantation: Comparison Between Everolimus-based And Conventional Immunosuppression
    FOerster, Julia
    Ahlenstiel-grunow, Thurid
    Kreuzer, Martin
    Pape, Lars
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1691 - 1692
  • [22] Dynamics of Pleural Effusions in the Presence of Everolimus-Based Immunosuppression in De Novo Cardiac Transplant Recipients
    Ross, H.
    Lehmkuhl, H.
    Wang, S. -S.
    Vigano, M.
    Zuckermann, A.
    Varnous, S.
    Frigerio, M.
    Laufer, G.
    Potena, L.
    Keogh, A.
    Livi, U.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (02): : S202 - S202
  • [23] Impact of de novo everolimus-based immunosuppression on wound healing and tissue regeneration in heart transplantation
    Zuckermann, A.
    Arizon, J.
    Wang, S. S.
    MacCherini, M.
    Vermes, E.
    Bara, C.
    Ross, H.
    Laufer, G.
    Lehmkuhl, H.
    Keogh, A. M.
    Sips, C.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S118 - S118
  • [24] PUBERTAL DEVELOPMENT AFTER PEDIATRIC KIDNEY TRANSPLANTATION: COMPARISON BETWEEN EVEROLIMUS-BASED AND CONVENTIONAL IMMUNOSUPPRESSION
    Pape, L.
    Ahlenstiel-Grunow, T.
    Foerster, J.
    Zapf, A.
    Mynarek, M.
    PEDIATRIC TRANSPLANTATION, 2015, 19 : 69 - 69
  • [25] CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN MAINTENANCE LIVER TRANSPLANT PATIENTS: RESULTS FROM 94 PATIENTS
    Vallin, Melanie
    Guillaud, Olivier
    Morard, Isabelle
    Gagnieu, Marie-Claude
    Mentha, Gilles
    Adham, Mustapha
    Morelon, Emmanuel
    Giostra, Emile
    Boillot, Olivier
    Dumortier, Jerome
    TRANSPLANT INTERNATIONAL, 2009, 22 : 120 - 120
  • [26] Everolimus-Based Immunosuppression Is Associated With a Reduced Risk of New-Onset Malignancies After Liver Transplantation
    De Simone, P.
    Carrai, P.
    Coletti, L.
    Ghinolfi, D.
    Campani, D.
    Filipponi, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [27] Everolimus-Based Immunosuppression Is Associated With a Reduced Risk of New-Onset Malignancies After Liver Transplantation
    De Simone, Paolo
    Carrai, Paola
    Ghinolfi, Davide
    Coletti, Laura
    Precisi, Arianna
    Campani, Daniela
    Filipponi, Franco
    TRANSPLANTATION, 2015, 99 : 91 - 92
  • [28] EVEROLIMUS-BASED IMMUNOSUPPRESSION TO REVERSE CALCINEURIN-INHIBITOR-ASSOCIATED MYOPATHIC SYMPTOMS IN HEART TRANSPLANT RECIPIENTS
    Meyer, S.
    Deuse, T.
    Baholli, L.
    Sattinger, E.
    Schlueter, M.
    von Stritzky, A.
    Reichenspurner, H.
    Costard-Jaeckle, A.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 46 - 47
  • [29] Targeted and global pharmacometabolomics in everolimus-based immunosuppression: association of co-medication and lysophosphatidylcholines with dose requirement
    Dorothea Lesche
    Vilborg Sigurdardottir
    Alexander B. Leichtle
    Christos T. Nakas
    Uwe Christians
    Lars Englberger
    Martin Fiedler
    Carlo R. Largiadèr
    Paul Mohacsi
    Johanna Sistonen
    Metabolomics, 2018, 14
  • [30] De Novo Everolimus-Based Immunosuppression in Liver Transplant Recipients; Retrospective Analysis of Safety and Efficacy.
    Nicolini, Daniele
    Del Pozo, Ana Carolina
    Di Giuseppe, Jacopo
    Vivarelli, Marco
    Garelli, Paolo
    Martorelli, Giacomo
    Vincenzi, Paolo
    Federici, Alen
    Gentili, Marco
    De Luca, Stefano
    Vecchi, Andrea
    Risaliti, Andrea
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 530 - 530